Entera Bio (ENTX) Operating Expenses (2019 - 2026)
Entera Bio's (ENTX) quarterly Operating Expenses came in at $3.5 million in Q1 2026, up 38.08% YoY from $2.6 million in Q1 2025, and up 16.34% on a QoQ basis from $3.0 million in Q4 2025.
Entera Bio (ENTX) Operating Expenses (2019 - 2026) Analysis & Trends
Entera Bio (ENTX) has 8 years of Operating Expenses data on file, last reported at $3.5 million in Q1 2026.
- Quarterly Operating Expenses rose 38.08% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.5 million (up 23.87% YoY) and the FY2025 annual result came in at $11.5 million, up 20.17% from the prior year.
- Operating Expenses rose to $3.5 million in Q1 2026, from $3.0 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $3.8 million in Q1 2022 to a low of $2.0 million in Q4 2023.
- A 5-year average of $2.7 million and a median of $2.7 million in 2025 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses surged 58.85% — and 2023, when it sank 42.53%.
- Tracing ENTX's Operating Expenses over 5 years: stood at $3.1 million in 2022, then sank by 36.14% to $2.0 million in 2023, then grew by 19.05% to $2.3 million in 2024, then soared by 30.17% to $3.0 million in 2025, then gained by 16.34% to $3.5 million in 2026.
- The last three Operating Expenses figures came in at $3.5 million (Q1 2026), $3.0 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 541.02 Mn |
| 10 | Entera Bio | 161.44 Mn | 150.13 Mn | - | 4.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.56 Mn |
| Mar 31, 2026 | 3.54 Mn |
| Dec 31, 2025 | 3.04 Mn |
| Sep 30, 2025 | 3.26 Mn |
| Jun 30, 2025 | 2.67 Mn |
| Mar 31, 2025 | 2.56 Mn |
| Dec 31, 2024 | 2.34 Mn |
| Sep 30, 2024 | 3.02 Mn |
| Jun 30, 2024 | 2.17 Mn |
| Mar 31, 2024 | 2.06 Mn |
| Dec 31, 2023 | 1.96 Mn |
| Sep 30, 2023 | 2.39 Mn |
| Jun 30, 2023 | 2.33 Mn |
| Mar 31, 2023 | 2.21 Mn |
| Dec 31, 2022 | 3.07 Mn |
| Sep 30, 2022 | 2.87 Mn |
| Jun 30, 2022 | 3.26 Mn |
| Mar 31, 2022 | 3.85 Mn |
| Dec 31, 2021 | 4.12 Mn |
| Sep 30, 2021 | 3.30 Mn |